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Abstract The ability of H2O2 and tributyltin (TBT) to trigger
pro-caspase activation via export of cytochrome c from
mitochondria to the cytoplasm was investigated. Treatment of
Jurkat T lymphocytes with H2O2 resulted in the appearance of
cytochrome c in the cytosol within 2 h. This was at least 1 h
before caspase activation was observed. TBT caused cytochrome
c release already after 5 min, followed by caspase activation
within 1 h. Measurement of mitochondrial membrane potential
(v8m) showed that both H2O2 and TBT dissipated v8m, but
with different time courses. TBT caused a concomitant loss of
v8m and release of cytochrome c, whereas cytochrome c release
and caspase activation preceded any apparent v8m loss in
H2O2-treated cells. Thus, our results suggest that different
mechanisms are involved in triggering cytochrome c release with
these apoptosis-inducing agents.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The caspase family of proteases plays a crucial role in apop-
tosis [1,2]. One of the earliest detectable changes in cells about
to undergo apoptosis is the conversion of cytoplasmic pro-
caspases to their active form. Active caspases then cleave a
number of de¢ned target proteins at aspartate residues, lead-
ing to the irreversible dismantling of the cell. Over-expression
of caspases induces apoptosis in various cell types, and pep-
tide inhibitors of the caspases block apoptosis induced by a
wide range of stimuli, emphasising the importance of caspase
activation for successful execution of apoptosis.
The ability of caspases to cleave and activate other cyto-
plasmic pro-caspases sets o¡ a destructive cascade of events
[1,2]. This cascade is likely to be a common pathway in apop-
tosis; however, the sequence of events leading to activation of
the ¢rst caspase(s) will vary depending on the apoptotic stim-
ulus. The best characterised systems are the cytotoxic T lym-
phocyte component granzyme B, which can directly cleave
several pro-caspases, including pro-caspase-10 [3], and ligation
of the Fas (APO-1/CD95) receptor, which initiates protein
interactions via ‘death domains’ and activation of caspase 8
[4]. For many other stimuli, the targeting of mitochondria to
release pro-apoptotic factors has been hypothesised to be a
primary event in caspase activation [5]. The release of cyto-
chrome c from the mitochondrial intermembrane space into
the cytosol has been detected in apoptotic cells and functions
in activation of caspase-3 [6^8]. Recent studies have shown
that microinjection of cytochrome c is su⁄cient to induce
apoptosis in some but not all cells [9,10].
The present study was to determine whether hydrogen per-
oxide or tributyltin, agents known to disrupt mitochondrial
function and induce apoptosis, stimulates mitochondrial cyto-
chrome c release and activation of caspase-3. Hydrogen per-
oxide induces apoptosis [11], and is also known to interfere
with mitochondrial functions. One prominent e¡ect of oxi-
dants is to activate the permeability transition pore with re-
sultant loss of the mitochondrial membrane potential (v8m)
[12]. Tributyltin is an immunotoxicant believed to cause thy-
mic atrophy by excessive stimulation of thymocyte apoptosis
[13]. The mechanism by which it induces apoptosis is currently
unclear, although earlier reports suggested that it may be
linked to an alteration in cellular calcium metabolism [14].
Toxicological studies demonstrated that the organotin family
of compounds are potent mitochondrial poisons [15]. The
present results show that both hydrogen peroxide and tribu-
tyltin induced cytochrome c release and activation of caspase-
3 with time courses consistent with a central role in activation
of apoptosis.
2. Materials and methods
2.1. Materials
Jurkat cells were obtained from the European Type Culture Col-
lection. Tributyltin chloride was from Merck (Darmstadt, Germany),
hydrogen peroxide from Fluka (Buchs, Switzerland), anti-Fas IgM
(CH-11) from Medical and Biological Laboratories (Nagoya, Japan),
z-VAD-fmk from Enzyme Systems Products (Livermore, CA, USA),
DEVD-AMC from Peptide Institute, Inc. (Osaka, Japan), JC-1
(5,5P,6,6P-tetrachloro-1,1P,3,3P-tetraethylbenzimidazole carbon cyanine
iodide) from Molecular Probes (Leiden, Netherlands), and anti-mouse
polyclonal cytochrome c antibody was a kind gift of Ronald Jemmer-
son, University of Minnesota, MN, USA. All other chemicals were
from Sigma (St. Louis, MO, USA).
2.2. Cell culture
Jurkat cells were maintained in logarithmic phase culture in RPMI-
1640 with 10% heat-inactivated foetal calf serum and 2 mM gluta-
mine, 100 U/ml penicillin, and 100 mg/ml streptomycin, at 37‡C in
humidi¢ed air with 5% carbon dioxide. Before use, cells were har-
vested at 500Ug for 5 min and re-suspended at 1U106/ml in fresh
medium.
2.3. Caspase activity
The measurement of DEVD-AMC cleavage was modi¢ed from
Nicholson et al. [16]. Cells were pelleted and frozen on microtitre
plates at 1U106 cells per 25 Wl. Fifty Wl of bu¡er (100 mM HEPES,
10% sucrose, 5 mM dithiothreitol, 1036% NP-40, and 0.1% CHAPS at
pH 7.25) was added to each well along with 50 WM of DEVD-AMC.
Substrate cleavage to release free AMC (ex. 355 nm, em. 460 nm) was
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monitored at 37‡C. Fluorescent units were converted to pmoles of
AMC using a standard curve generated with free AMC.
2.4. Cytochrome c release
Cells were harvested by centrifugation at 500Ug for 5 min. Cyto-
plasmic extracts were prepared as described by Liu et al. [6]. The
bu¡er included 20 mM HEPES (pH 7.5 with KOH), 10 mM KCl,
1.5 mM MgCl2, 1 mM EGTA, 1 mM EDTA, 1 mM DTT, 0.1 mM
PMSF, 5 Wg/ml pepstatin A, 10 Wg/ml leupeptin, 2 Wg/ml aprotinin,
and 25 Wg/ml calpain inhibitor I. Protein concentrations varied from
2^5 Wg/Wl of extract (Bio-Rad protein assay with BSA as the stand-
ard).
2.5. Western blotting
Sample extracts (20 Wg/ml) were loaded onto a 15% SDS-polyacryl-
amide gel and electrophoresed at 130 V for 2 h, then transferred to
PVDF membranes (Bio-Rad) at 100 V over a further 2 h. Membranes
were blocked in 50 mM Tris (pH 7.5) with 500 mM NaCl, 1% BSA,
and 5% non-fat dried milk. The membranes were then probed with
anti-cytochrome c antibodies (1:500) in an identical solution, followed
by peroxidase labelled anti-mouse antibodies (1:10 000) and visualised
by ECL (Amersham, Buckinghamshire, UK).
2.6. Mitochondrial membrane potential
Cells were incubated with JC-1 (10 Wg/ml) for 10 min in the dark at
room temperature, then washed twice in PBS and analysed in a Bec-
ton Dickinson FACScan £ow cytometer, using the parameters de-
scribed by Cossarizza et al. [18].
3. Results
We quantitated caspase activity in Jurkat cells by measuring
cleavage of the £uorescent peptide Ac-Asp-Glu-Val-Asp-(7-
amino-4-methylcoumarin) (DEVD-AMC) [16]. This peptide
mimics the target sequence of the group II e¡ector caspases,
and as such, is an ideal substrate for determining if the cas-
pase cascade has been triggered in the cells of interest.
The ¢rst apoptotic stimulus tested was hydrogen peroxide.
We have previously documented its ability to activate the
caspases and induce apoptosis [11], and Kluck et al. [8] have
reported cytochrome c release in hydrogen peroxide-treated
CEM cells. However, there has been no report of whether
cytochrome c release occurs before caspase activation in any
of these systems. Treatment of Jurkat cells (106/ml) with 50
WM hydrogen peroxide resulted in caspase activity above con-
trol levels within 3^4 h (Fig. 1A). Cytosolic extracts were
obtained from the same cells, and Western blot analysis of
cytochrome c levels was performed. Cytochrome c appearance
in the cytoplasm was clearly detectable by 2 h, i.e. 1^2 h
before caspase activation. Export was not a¡ected by addition
of the general caspase inhibitor z-VAD-fmk (Fig. 1B). There-
fore, release of mitochondrial cytochrome c occurred early
enough to be responsible for caspase activation by hydrogen
peroxide.
The mechanism for the export of cytochrome c from mito-
chondria is unknown. Hydrogen peroxide can induce the mi-
tochondrial permeability transition (MPT) and cause a loss in
the mitochondrial membrane potential (v8m) [17] in a process
thought to be important in activation of apoptosis [5]. To
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Fig. 1. Time course of caspase activation, cytochrome c release and
mitochondrial membrane potential in Jurkat cells treated with hy-
drogen peroxide. Jurkat cells (106/ml) were treated with 50 WM hy-
drogen peroxide in the presence or the absence of the protease in-
hibitor z-VAD-fmk. At various times after treatment the cells were
harvested. A: Caspase activity was measured by the ability of cellu-
lar extracts to cleave DEVD-AMC. B: The presence of cytochrome
c in cytoplasmic extracts was measured by Western blot with an
anti-cytochrome c antibody. C: The JC-1 monomers were measured
by £ow cytometry in 10 000 cells. The dotted lines represent un-
treated cells at each time. Results are representative of at least 3 ex-
periments.
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investigate whether a decrease in v8m could activate cyto-
chrome c release in the hydrogen peroxide model, we used
the £uorescent dye JC-1 to measure v8m following treatment.
This mitochondrial speci¢c dye forms aggregates at the nor-
mal membrane potential, and a loss in v8m can be monitored
by £ow cytometry as an increase in JC-1 monomers (FL-1
channel) [18,19]. We detected a loss in the v8m with hydrogen
peroxide, but not until 4 h (Fig. 1C), indicating that it was
unlikely to be involved in hydrogen peroxide-mediated cyto-
chrome c export.
The second agent investigated was tributyltin, which is
known to be an e¡ective inducer of apoptosis [13,20] but
the role of cytochrome c release and caspase activation has
not been determined. Addition of 2 WM tributyltin resulted in
caspase activation within 60 min (Fig. 2A), and maximal cy-
tochrome c release was detected within 5^10 min (Fig. 2B), i.e.
well before caspase activity could be detected. z-VAD-fmk
had no e¡ect on cytochrome c release by tributyltin, consis-
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Fig. 3. Time course of caspase activation, cytochrome c release and
mitochondrial membrane potential in Jurkat cells treated with anti-
Fas antibody. Experiments were performed as in Fig. 1, except cells
were treated with 250 ng/ml anti-Fas antibody.
Fig. 2. Time course of caspase activation, cytochrome c release and
mitochondrial membrane potential in Jurkat cells treated with tribu-
tyltin. Experiments were performed as in Fig. 1, except cells were
treated with 2 WM tributyltin.
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tent with this process occurring upstream of caspase activa-
tion.
While quantitation from the Western blots is di⁄cult, com-
parison with the amount of cytochrome c released from Tri-
ton X-100-lysed mitochondria indicates that tributyltin and
hydrogen peroxide caused the release of a large amount of
total mitochondrial cytochrome c (Figs. 1B and 2B). The
amounts released did appear to plateau though, suggesting
that either a speci¢c fraction of the hemoprotein was available
for export, or that part of the mitochondrial population re-
sisted the cytochrome c releasing e¡ects of tributyltin and
hydrogen peroxide.
As expected from early toxicological studies, tributyltin in-
duced a rapid dissipation of v8m, making this e¡ect a poten-
tial mechanism for cytochrome c export (Fig. 2C). However,
because of the rapid time course of tributyltin-induced loss of
v8m, and cytochrome c release, it was not possible to discern
which came ¢rst in this model.
To compare the results obtained with the two mitochon-
drial toxicants, we induced apoptosis with an anti-Fas anti-
body which is thought to occur by a mechanism without early
mitochondrial involvement. With this treatment cytochrome c
release and DEVD-AMC cleavage were measured after 2 h
and both were prevented by z-VAD-fmk (Fig. 3B,C), indicat-
ing that they were the e¡ects rather than the causes of caspase
activation. As with hydrogen peroxide treatment, loss of v8m
was a late event that did not appear to be important in either
cytochrome c release or caspase activation.
4. Discussion
Mitochondria are thought to play a central role in the acti-
vation of apoptosis induced by multiple agents by a mecha-
nism that involves release of cytochrome c and its binding to a
multiprotein complex that activates caspase-3. This may pro-
vide a general mechanism whereby agents that induce mito-
chondrial dysfunction activate apoptosis. Here we show that
hydrogen peroxide and tributyltin, two agents known to dis-
rupt mitochondrial function, can trigger cytochrome c release
su⁄ciently early to account for caspase activation. This adds
to a growing list of toxic exposures, including etoposide, pa-
clitaxel, UVB, ionizing radiation and MPP, where mitochon-
drial cytochrome c release precedes activation of caspase-3.
Thus, accumulating data indicate that mitochondrial cyto-
chrome c release is an early common event in the induction
of apoptosis induced by many toxic conditions.
However, despite this apparently common role of cyto-
chrome c in activation of caspases, the mechanisms involved
in its release from mitochondria appear to di¡er for di¡erent
activating agents. Oxidative stress is known to alter various
facets of mitochondrial function including calcium homeosta-
sis and triggering of the permeability transition pore, leading
to a dissipation of v8m [17]. It has been proposed that the
transition pore and associated loss in v8m could be respon-
sible for the release of proapoptotic factors such as cyto-
chrome c [21]. However, we could detect no link between
the v8m and cytochrome c release with hydrogen peroxide
where loss in v8m was detectable, but only 1^2 h after cyto-
chrome c release.
Other evidence also appears to exclude the general involve-
ment of v8m in cytochrome c release. Carbonyl cyanide m-
chlorophenylhydrazone (CCCP), which rapidly dissipates
v8m, was not able to trigger cytochrome c release (result
not shown). Yang et al. [7] and Kluck et al. [8] could not
detect changes in v8m in their apoptotic models. Also, other
reports of a loss in v8m during apoptosis place it at a similar
time [22] or after [23] glutathione loss in apoptotic cells. We
have previously characterised the export of glutathione from
apoptotic cells to be a mid to late event in apoptotic cells,
clearly downstream of caspase activation [24].
In contrast, a loss of v8m could play a role in the tribu-
tyltin model. Tributyltin dissipated v8m very quickly, with a
concomitant release of mitochondrial cytochrome c. The ef-
fects of organotin compounds on cell function were studied
extensively during the 1950’s. Trialkyltin compounds act as
Cl3/OH3 exchangers, which could provide an explanation
for the rapid dissipation of v8m and blocking of oxidative
phosphorylation [25]. They were also shown to directly inhibit
the mitochondrial ATP synthase, and cause mitochondrial
swelling [25]. In another study, we attempted to block
tributyltin- induced loss of v8m with bongkrekic acid, an
agent that inhibits MPT, but observed no inhibition. Thus,
the results suggest that the loss of v8m induced by tributyltin
may involve Cl3/OH3 exchange or other mechanisms not
directly linked to the MPT. Alternatively, bongkrekic acid
may not be su⁄ciently permeable to inhibit MPT in the cells.
Further studies are required to determine which, if any, of
these e¡ects are involved in tributyltin-mediated cytochrome
c release.
Mitochondria are not generally implicated in transduction
of the Fas signal. The sequence of events following trimerisa-
tion of the Fas receptor has been shown to include direct
activation of caspase-8 (FLICE/MACH) at the cytosolic site
of the receptor [26]. Caspase-8 can cleave and activate the
DEVD-cleaving group II caspases such as caspase-3, thereby
eliminating the requirement for additional factors in caspase
activation. While a mechanism whereby Fas activates caspase-
1, which then acts on the mitochondria to cause release of
other caspase-activating agents, has been proposed [21], it
remains to be shown if these changes occur before activation
of the group II caspases. Our present ¢ndings exclude cyto-
chrome c from being one of these caspase-activating factors as
it is not exported in the time frame necessary.
The ability of the non-speci¢c caspase inhibitor z-VAD to
prevent Fas-mediated cytochrome c release shows, however,
that activated caspases can alter mitochondrial function. Ba-
bior, Gottlieb and colleagues [27,28] have reported impaired
mitochondrial function in Fas-treated Jurkat cells that corre-
sponded with a caspase-dependent loss in cytochrome c. In-
terestingly, however, their e¡ect was observed within 5 min
and was attributed to an inactivation of cytochrome c, with-
out export from the mitochondria.
A loss of v8m was observed after cytochrome c release in
hydrogen peroxide- and Fas-mediated apoptosis. These results
indicate that the export of cytochrome c does not occur as a
consequence of activating the permeability transition pore,
which is associated with a loss of v8m. Therefore, speci¢c
export mechanisms should be considered. Van der Heiden et
al. [29] have recently reported a novel mechanism. They sug-
gest that swelling and rupture of the outer mitochondrial
membrane leads to release of cytochrome c, without disrup-
tion of the inner membrane and v8m. This was observed
upon treatment of Jurkat cells with anti-Fas or staurosporine,
and interleukin 3 deprivation of a pro B-cell line. The mech-
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anism remains to be clari¢ed, but alterations in mitochondrial
volume homeostasis were implicated.
In summary, the present studies show that two mitochon-
drial toxicants induce cytochrome c release and caspase acti-
vation with a time course appropriate for a role in the signal-
ling of apoptosis. Tributyltin causes a rapid loss of the
mitochondrial membrane potential that cannot be temporally
separated from cytochrome c release. In contrast, the mito-
chondrial membrane potential is retained in peroxide-treated
cells until well after release of cytochrome c and caspase acti-
vation. Thus, at least for hydrogen peroxide treatment, cyto-
chrome c release appears to occur by a more speci¢c mecha-
nism than the permeability transition pore.
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